Indivior PLC Ordinary Shares (INDV) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported INDV revenue for 2025-12-31 was $1.24B. Net income was $210.0M. Revenue was up 4.3% from 2024-12-31 to 2025-12-31. INDV currently screens at market cap $4.48B and trailing P/E 19.5.
Use this INDV page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the INDV quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the INDV SEC filings page. Lician reads the product cache first so this HTML stays unique to Indivior PLC Ordinary Shares even when a live quote feed is slow.
Latest cached year on this hub. Full INDV income, balance, and cash tables.